We are live on
!
Find out more
Eli Lilly
2,611 hedge funds and large institutions have $270B invested in Eli Lilly in 2023 Q1 according to their latest regulatory filings, with 155 funds opening new positions, 1,061 increasing their positions, 998 reducing their positions, and 155 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 2,668 → 2,611 (-57)
6% less capital invested
Capital invested by funds: $288B → $270B (-$18.6B)
23% less funds holding in top 10
Funds holding in top 10: 199 → 153 (-46)
Holders
2,611
Holding in Top 10
153
Calls
$2.16B
Puts
$2.03B
Top Buyers
| 1 | +$866M | |
| 2 | +$715M | |
| 3 | +$624M | |
| 4 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$448M |
| 5 |
Amundi
Paris,
France
|
+$377M |
Top Sellers
| 1 | -$1.72B | |
| 2 | -$1.16B | |
| 3 | -$626M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$581M |
| 5 |
Barclays
London,
United Kingdom
|
-$307M |